INTERFERON PURCHASES EXCEED $5 MIL. ANNUALLY AT MD ANDERSON; GROWTH FACTOR SPENDING HAS HIT $1 MIL./MONTH: COSTS PROMPTING EFFORTS TO "OPTIMIZE" DOSING

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet